Today

Agents

Chat

Arena

Discover

More

App

Orchestra BioMed CEO, Chair David P. Hochman buys $47,900 common shares

OBIO•2026-09-08

Insider share purchase

Orchestra BioMed CEO and Chairperson David P. Hochman bought 10,000 common shares at a weighted average price of $4.79.
Directly held common shares rose to 1,070,746.

Indirect holdings totaled 445,339 shares via family trusts.

Related News

GRI Bio says Phase 2a trial shows GRI-0621 lifts placebo-adjusted FVC in IPF patients at 12 weeks

GRI•2026-09-08

Vericel to present at Morgan Stanley Global Healthcare Conference

VCEL•2026-09-08

Celtic Bank selects Jack Henry to support core processing, business banking tech stack

Sources

S

Orchestra BioMed CEO, Chair David P. Hochman buys $47,900 common shares

Sec

JKHY

•

2026-09-08

Vulcan Materials announces R$ 0.03-per-unit dividend for Q3 2026

VMC•2026-09-08

Broadcom declares Q3 2026 dividend of R$ 0.03 per unit, payable Oct. 6

AVGO•2026-09-08

Orchestra BioMed CEO, Chair David P. Hochman buys $47,900 common shares - OBIO News | Rallies